2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

@article{Levine20112011AG,
  title={2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.},
  author={G. Levine and E. Bates and J. Blankenship and S. Bailey and J. A. Bittl and B. Cercek and C. Chambers and S. Ellis and R. Guyton and S. Hollenberg and U. Khot and R. A. Lange and L. Mauri and R. Mehran and I. Moussa and D. Mukherjee and B. Nallamothu and H. Ting},
  journal={Journal of the American College of Cardiology},
  year={2011},
  volume={58 24},
  pages={
          e44-122
        }
}
  • G. Levine, E. Bates, +15 authors H. Ting
  • Published 2011
  • Medicine
  • Journal of the American College of Cardiology
  • The medical profession should play a central role in evaluating the evidence related to drugs, devices, and procedures for the detection, management, and prevention of disease. When properly applied, expert analysis of available data on the benefits and risks of these therapies and procedures can 

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    Comparison of Angiography-derived Fractional FLow Reserve And IntraVascular Ultrasound-guided Intervention Strategy for Clinical OUtcomes in Patients with CoRonary Artery Disease  
    ConditionsCoronary Artery Disease
    InterventionProcedure
    INTERVENTIONAL CLINICAL TRIAL
    The APLABE-PCI is a single-center, randomized, open-label, controlled, dose-escalating, parallel-group study, which is designed to assess the anti-platelet effect of berberine in… Expand
    ConditionsCoronary Artery Disease, Percutaneous Coronary Intervention
    InterventionDrug
    OBSERVATIONAL PATIENT REGISTRY CLINICAL TRIAL
    The use of fractional flow reserve (FFR) has improved outcomes in percutaneous coronary interventions (PCI) in patients with symptomatic stable coronary artery disease (CAD) with… Expand
    ConditionsCoronary Artery Disease
    InterventionDiagnostic Test

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 1,057 REFERENCES